The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
about
Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled TrialsFRMD3 gene: its role in diabetic kidney disease. A narrative reviewPerspectives on systems biology applications in diabetic kidney diseaseTherapeutic modalities in diabetic nephropathy: standard and emerging approaches.Type 1 diabetes mellitus.Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end productsRenal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function.Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial.Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year resultsDiagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuriaSources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of DiseaseSoluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-upPrevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy.Aberrant DNA methylation patterns in diabetic nephropathyDevelopment and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance.Diabetic kidney disease: from epidemiology to clinical perspectives.Studies on the safety of creatine supplementation.Urinary alpha- and pi-glutathione s-transferases in adult patients with type 1 diabetesRenal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes.Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigsGenetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation.Protein glycation in diabetes as determined by mass spectrometry.Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS).Screening and prevention of chronic kidney disease.Zinc status in type 2 diabetic patients: relation to the progression of diabetic nephropathy.Microalbuminuria, is it so important?Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy.Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes.Preventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control.ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.Microvascular basement membranes in diabetes mellitus.Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db miceEarly-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease.Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective.
P2860
Q26745523-96297745-31F8-4613-A801-93BF824FEBB4Q26768469-3F8EF72E-FE6D-4498-8EE3-BBC6F4CA48A0Q26771495-C2E04FB4-23D7-46F2-A359-44CE4037FB3BQ26823206-0F31A83A-ACA6-4199-8EAE-30636D8B01E1Q27007027-F8F81519-722A-4E32-ABB9-D73FF4644252Q30235021-1C0A2EA6-3446-42A9-901B-080EB576C682Q30410401-2C1AC10E-3734-459F-8772-DBF844005A11Q30556744-25702FEB-88CD-482D-AAD4-5C1AA85AA570Q30658906-DE60AC56-B463-47BA-A3B9-6931C50239FBQ33233345-3401EB8B-7404-4E6E-9FDC-52B4BFC364C0Q33307444-4C999A65-5276-476E-8D09-1A4CE664B5D1Q33488868-89B9636E-9551-44DF-BA94-8FC354BF97ADQ33597457-7F4FEB5C-70F8-4394-88E8-5C955125FE3BQ33741426-CED32743-4460-486B-A4B0-5DA5B4260495Q33873169-6EAEAEB4-2A62-45DE-B9AA-BD5F51114E45Q33899286-1E08677D-0411-43FC-A07C-0C8730A2CABDQ33904741-5B6F7F17-4489-470C-AFDE-CD2F563787BFQ33932739-8D471099-0DA1-4E0C-8A43-43104C4AFD26Q33986978-0FF64B35-CFDB-401E-BB9E-1A8AEFA1222BQ34161874-601BB020-D514-4B06-AE30-754F95891760Q34170475-162995D3-7130-490B-97FC-F421DF9E5D6FQ34181053-C84595A4-A9AE-45CD-8552-A0F43F555905Q34419136-35852295-E8A5-4A51-9A91-CB4E1EA488C5Q34551722-E2F9505B-B75B-4B43-BD18-FBBE2F7642C6Q34631925-D6E32FE8-B3C7-434A-899F-7C935A0AC1AAQ34661579-8CA350EB-FF91-458F-8048-381254905987Q34768539-E3804577-4306-4F6B-B708-BC26537247B3Q34769759-D5CE048F-FB77-45F6-846F-B6DBA3FB6895Q34909787-D42FE32F-93EB-4FA7-B7DD-15F752D6476CQ34990976-1613293C-BD76-4E50-814A-E80C63000745Q35043750-123EE955-E0CB-4BD3-9740-09B20C6D3924Q35065524-CB1B5B84-062E-4116-A6E5-9DE3B9000280Q35095210-10128A9C-577C-40F6-BB6A-86D5E19B79BCQ35106214-BDDAD5D9-3030-4152-B5E6-D78766DE35B0Q35170462-8133EA0A-1B71-4A3D-BC9A-B3A6797EEBC5Q35190860-77EBF45B-937F-4882-8DE4-0B7926D899F2Q35591301-4DC1E778-1F2C-469E-81C4-4490261017D4Q35630730-BE4721FF-B40C-4522-8A3E-983846800F23Q35646060-296F573C-C236-4C6C-8FD5-D649777E5145Q35648485-E96B71F4-498F-4FF3-AE0E-A248AC808A80
P2860
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The need for early predictors ...... min excretion rate sufficient?
@ast
The need for early predictors ...... min excretion rate sufficient?
@en
The need for early predictors ...... min excretion rate sufficient?
@nl
type
label
The need for early predictors ...... min excretion rate sufficient?
@ast
The need for early predictors ...... min excretion rate sufficient?
@en
The need for early predictors ...... min excretion rate sufficient?
@nl
prefLabel
The need for early predictors ...... min excretion rate sufficient?
@ast
The need for early predictors ...... min excretion rate sufficient?
@en
The need for early predictors ...... min excretion rate sufficient?
@nl
P2093
P1433
P1476
The need for early predictors ...... min excretion rate sufficient?
@en
P2093
P304
P356
10.2337/DIABETES.49.9.1399
P407
P577
2000-09-01T00:00:00Z